JP2024522193A5 - - Google Patents

Info

Publication number
JP2024522193A5
JP2024522193A5 JP2023576010A JP2023576010A JP2024522193A5 JP 2024522193 A5 JP2024522193 A5 JP 2024522193A5 JP 2023576010 A JP2023576010 A JP 2023576010A JP 2023576010 A JP2023576010 A JP 2023576010A JP 2024522193 A5 JP2024522193 A5 JP 2024522193A5
Authority
JP
Japan
Prior art keywords
antigen
influenza virus
seq
immune response
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023576010A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522193A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/032799 external-priority patent/WO2022261297A2/en
Publication of JP2024522193A publication Critical patent/JP2024522193A/ja
Publication of JP2024522193A5 publication Critical patent/JP2024522193A5/ja
Pending legal-status Critical Current

Links

JP2023576010A 2021-06-10 2022-06-09 免疫原としての広範囲反応性ウイルス抗原、その組成物及び使用方法 Pending JP2024522193A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209209P 2021-06-10 2021-06-10
US63/209,209 2021-06-10
PCT/US2022/032799 WO2022261297A2 (en) 2021-06-10 2022-06-09 Broadly reactive viral antigens as immunogens, compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024522193A JP2024522193A (ja) 2024-06-11
JP2024522193A5 true JP2024522193A5 (enExample) 2025-10-29

Family

ID=84426405

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023576010A Pending JP2024522193A (ja) 2021-06-10 2022-06-09 免疫原としての広範囲反応性ウイルス抗原、その組成物及び使用方法

Country Status (7)

Country Link
US (1) US20240100148A1 (enExample)
EP (1) EP4351637A4 (enExample)
JP (1) JP2024522193A (enExample)
CN (1) CN117693359A (enExample)
AU (1) AU2022289009A1 (enExample)
CA (1) CA3221953A1 (enExample)
WO (1) WO2022261297A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025038695A1 (en) * 2023-08-14 2025-02-20 The Wistar Institute Of Anatomy And Biology Modified h3 hemagglutinin antigens and methods of use thereof
WO2025179103A1 (en) * 2024-02-23 2025-08-28 University Of Georgia Research Foundation, Inc. Pentavalent and octavalent influenza virus immunogens, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120219584A1 (en) * 2009-10-05 2012-08-30 The United States Of America As Represented By The Secretary, Department Of Health Protection against pandemic and seasonal strains of influenza
EP3233116A4 (en) * 2014-12-19 2018-05-30 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for h1n1 influenza
WO2017053374A1 (en) * 2015-09-21 2017-03-30 Oregon Health & Science University Design and characterization of influenza vaccines
US20200237898A1 (en) * 2015-09-21 2020-07-30 Oregon Health & Science University Vaccines intelligently produced by epitope recombination (viper) for influenza
WO2020092207A1 (en) * 2018-10-28 2020-05-07 University Of Georgia Research Foundation Broadly reactive immunogens of influenza virus, compositions, and methods of use thereof
WO2020172365A1 (en) * 2019-02-21 2020-08-27 University Of Georgia Research Foundation Broadly reactive immunogens of h5 influenza virus, compositions and methods of use thereof
AU2020263900B2 (en) * 2019-04-25 2026-04-16 Janssen Vaccines & Prevention B.V. Recombinant influenza antigens

Similar Documents

Publication Publication Date Title
US12005111B2 (en) Zika virus vaccine
US12239699B2 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
TWI688652B (zh) 作為對抗腸病毒感染之免疫原的病毒顆粒及其製造
US20080063649A1 (en) Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
CN102399757A (zh) 免疫原性组合物及其用途
CN112691189A (zh) 一种猫传染性腹膜炎病毒亚单位疫苗及应用
JP2023522154A5 (enExample)
AU2016313660B2 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
JP2014502143A5 (enExample)
Lim et al. RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform
CN102813920A (zh) 一种疫苗佐剂
CN117693359A (zh) 作为免疫原的广泛反应性病毒抗原、其组合物和使用方法
CN1338310A (zh) 一种猪瘟病毒表位疫苗及其制备方法
TW202112394A (zh) 以肽核酸為基礎之佐劑
US20150359877A1 (en) Viral Vaccine Vectors
JP2022513438A5 (enExample)
CN110204613B (zh) 一种针对胡宁病毒的中和抗体、其制备方法及其应用
RU2442604C1 (ru) Способ усиления иммунного ответа
JP2024543954A5 (enExample)
KR20240051039A (ko) 인플루엔자 A 바이러스 항원 단백질 HA, NA 또는 M2e5x를 포함하는 바이러스 유사입자 조합 백신
EP4440605A1 (en) Immunogens targeting anthrax
HK40098392A (en) Zika virus vaccine
WO2023201881A1 (zh) 香菇多糖在制备新型冠状病毒呼吸道粘膜疫苗中的应用
CA2996497C (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN1338308A (zh) 一种合成肽流感疫苗及其制备方法